L N Mkrtchian, S G Shukurian, L A Kamalian, K A Aleksanian, A M Ambartsumian
{"title":"[肿瘤患者病理治疗新方法的发展]。","authors":"L N Mkrtchian, S G Shukurian, L A Kamalian, K A Aleksanian, A M Ambartsumian","doi":"","DOIUrl":null,"url":null,"abstract":"<p><p>Basing on the current data and results of the author's own clinical and experimental studies the possibility to intensify the antitumoural resistivity of the organism was established. This may be performed due to demasking of tumour cells using fibrinolytic agents, selective inhibition of tumour cell division by keilons, tissue-specific inhibitors, and also by normalization of the interferon system function.</p>","PeriodicalId":77530,"journal":{"name":"Eksperimental'naia onkologiia","volume":"12 1","pages":"13-5"},"PeriodicalIF":0.0000,"publicationDate":"1990-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"[Development of a new approach to the pathogenetic therapy of oncological patients].\",\"authors\":\"L N Mkrtchian, S G Shukurian, L A Kamalian, K A Aleksanian, A M Ambartsumian\",\"doi\":\"\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><p>Basing on the current data and results of the author's own clinical and experimental studies the possibility to intensify the antitumoural resistivity of the organism was established. This may be performed due to demasking of tumour cells using fibrinolytic agents, selective inhibition of tumour cell division by keilons, tissue-specific inhibitors, and also by normalization of the interferon system function.</p>\",\"PeriodicalId\":77530,\"journal\":{\"name\":\"Eksperimental'naia onkologiia\",\"volume\":\"12 1\",\"pages\":\"13-5\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"1990-01-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Eksperimental'naia onkologiia\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Eksperimental'naia onkologiia","FirstCategoryId":"1085","ListUrlMain":"","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
[Development of a new approach to the pathogenetic therapy of oncological patients].
Basing on the current data and results of the author's own clinical and experimental studies the possibility to intensify the antitumoural resistivity of the organism was established. This may be performed due to demasking of tumour cells using fibrinolytic agents, selective inhibition of tumour cell division by keilons, tissue-specific inhibitors, and also by normalization of the interferon system function.
求助内容：
应助结果提醒方式：
京公网安备 11010802042870号
